In:
Angiology, SAGE Publications, Vol. 66, No. 6 ( 2015-07), p. 503-507
Kurzfassung:
The assessment of cardiovascular risk and treatment of cardiovascular diseases are major public health issues worldwide. Inflammation is now recognized as a key regulatory process that links multiple risk factors for atherosclerosis. The substantial number of patients having cardiovascular events lack commonly established risk factors. The utility of high-sensitivity C-reactive protein (hsCRP), a circulating biomarker related to inflammation, may provide additional information in risk prediction. This review will consider the impact of hsCRP level on initiation of statin therapy.
Materialart:
Online-Ressource
ISSN:
0003-3197
,
1940-1574
DOI:
10.1177/0003319714543000
Sprache:
Englisch
Verlag:
SAGE Publications
Publikationsdatum:
2015
ZDB Id:
2065911-8